Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To date, this is the first report to monitor changes of intratumor vascularization and the response to radiation and Cyberknife therapy in a patient with recurrent primary papillary serous carcinoma of the peritoneum by three dimensional (3D) power Doppler ultrasonography (PDUS). Transvaginal 3D PDUS detected a recurrent presacral tumor with abundant intratumor vascularity. Serial examinations of the tumor volume and serum CA-125 level were studied before, during, and 6 mo after therapy. Meanwhile, the intratumor blood flow was measured and expressed as vascularity indices. All of the tumor volume, intratumor vascularity indices and serum CA-125 level decreased progressively following therapy. A remaining lesion with nearly absent intratumor power Doppler signals suggested a scarring lesion posttreatment. Indeed, CT-guided tissue biopsy confirmed fibrotic change. 3D PDUS is useful to monitor the response to treatments and to differentiate residual tumors from lesions of scarring change posttreatment. It provides more accurate posttreatment information than pelvic computed tomography. (E-mail: chougyn@mail.ncku.edu.tw).

Original languageEnglish
Pages (from-to)623-626
Number of pages4
JournalUltrasound in Medicine and Biology
Volume32
Issue number5
DOIs
Publication statusPublished - 2006 May 1

Fingerprint

peritoneum
Doppler Ultrasonography
Papillary Carcinoma
Peritoneum
tumors
cancer
lesions
Tumor Burden
therapy
Cicatrix
serums
Residual Neoplasm
Postal Service
Serum
Radiotherapy
Therapeutics
blood flow
Tomography
Biopsy
radiation therapy

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Biophysics
  • Acoustics and Ultrasonics

Cite this

@article{8e728c39d87c4da1814540c22cc54853,
title = "Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum",
abstract = "To date, this is the first report to monitor changes of intratumor vascularization and the response to radiation and Cyberknife therapy in a patient with recurrent primary papillary serous carcinoma of the peritoneum by three dimensional (3D) power Doppler ultrasonography (PDUS). Transvaginal 3D PDUS detected a recurrent presacral tumor with abundant intratumor vascularity. Serial examinations of the tumor volume and serum CA-125 level were studied before, during, and 6 mo after therapy. Meanwhile, the intratumor blood flow was measured and expressed as vascularity indices. All of the tumor volume, intratumor vascularity indices and serum CA-125 level decreased progressively following therapy. A remaining lesion with nearly absent intratumor power Doppler signals suggested a scarring lesion posttreatment. Indeed, CT-guided tissue biopsy confirmed fibrotic change. 3D PDUS is useful to monitor the response to treatments and to differentiate residual tumors from lesions of scarring change posttreatment. It provides more accurate posttreatment information than pelvic computed tomography. (E-mail: chougyn@mail.ncku.edu.tw).",
author = "Su, {Jen Min} and Yu-Fang Huang and Chen, {Helen H.W} and Ya-Min Cheng and Cheng-Yang Chou",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.ultrasmedbio.2006.01.005",
language = "English",
volume = "32",
pages = "623--626",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum

AU - Su, Jen Min

AU - Huang, Yu-Fang

AU - Chen, Helen H.W

AU - Cheng, Ya-Min

AU - Chou, Cheng-Yang

PY - 2006/5/1

Y1 - 2006/5/1

N2 - To date, this is the first report to monitor changes of intratumor vascularization and the response to radiation and Cyberknife therapy in a patient with recurrent primary papillary serous carcinoma of the peritoneum by three dimensional (3D) power Doppler ultrasonography (PDUS). Transvaginal 3D PDUS detected a recurrent presacral tumor with abundant intratumor vascularity. Serial examinations of the tumor volume and serum CA-125 level were studied before, during, and 6 mo after therapy. Meanwhile, the intratumor blood flow was measured and expressed as vascularity indices. All of the tumor volume, intratumor vascularity indices and serum CA-125 level decreased progressively following therapy. A remaining lesion with nearly absent intratumor power Doppler signals suggested a scarring lesion posttreatment. Indeed, CT-guided tissue biopsy confirmed fibrotic change. 3D PDUS is useful to monitor the response to treatments and to differentiate residual tumors from lesions of scarring change posttreatment. It provides more accurate posttreatment information than pelvic computed tomography. (E-mail: chougyn@mail.ncku.edu.tw).

AB - To date, this is the first report to monitor changes of intratumor vascularization and the response to radiation and Cyberknife therapy in a patient with recurrent primary papillary serous carcinoma of the peritoneum by three dimensional (3D) power Doppler ultrasonography (PDUS). Transvaginal 3D PDUS detected a recurrent presacral tumor with abundant intratumor vascularity. Serial examinations of the tumor volume and serum CA-125 level were studied before, during, and 6 mo after therapy. Meanwhile, the intratumor blood flow was measured and expressed as vascularity indices. All of the tumor volume, intratumor vascularity indices and serum CA-125 level decreased progressively following therapy. A remaining lesion with nearly absent intratumor power Doppler signals suggested a scarring lesion posttreatment. Indeed, CT-guided tissue biopsy confirmed fibrotic change. 3D PDUS is useful to monitor the response to treatments and to differentiate residual tumors from lesions of scarring change posttreatment. It provides more accurate posttreatment information than pelvic computed tomography. (E-mail: chougyn@mail.ncku.edu.tw).

UR - http://www.scopus.com/inward/record.url?scp=33646140777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646140777&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2006.01.005

DO - 10.1016/j.ultrasmedbio.2006.01.005

M3 - Article

C2 - 16677920

AN - SCOPUS:33646140777

VL - 32

SP - 623

EP - 626

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 5

ER -